SEC Form 4 · accession 0001674236-26-000022
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen P. Carey
Officer — SVP & CFO
Period of report
Aug 31, 2026
Accepted (ET)
Sep 1, 2026 · 6:18 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 31, 2026 | S | 2,850 | $72.80 | D | 171,843 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.
- F2The shares were sold in multiple trades at prices ranging from $71.89 to $73.36. The price reported above reflects the weighted average sales price.